AAV-Gene Therapy Platform
Total Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
245
NCT06591806
An Observational Study in Children and Adults With Stargardt Disease
Phase: N/A
Role: Lead Sponsor
Start: May 1, 2024
Completion: Jun 30, 2027
NCT06591793
Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa
Phase: Phase 1/2
Start: Jul 2, 2024
Completion: Jul 31, 2029
NCT07161544
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
Start: Sep 30, 2025
Completion: Jul 31, 2032
Role: Collaborator
Loading map...